CrizotinibDevelopment of resistance during treatment for non-small cell lung cancer: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1666卷 / 1期

关键词：

D O I：

10.1007/s40278-017-34933-5

中图分类号：

学科分类号：

摘要：

引用

页码：91 / 91

共 50 条

[31] AtezolizumabHyperprogression of non-small cell lung cancer: case report
Reactions Weekly, 2020, 1789 (1) : 52 - 52
[32] PembrolizumabHyperprogression of non-small cell lung cancer : case report
Reactions Weekly, 2024, 2020 (1) : 379 - 379
[33] PembrolizumabHyperprogression of non-small cell lung cancer: case report
Reactions Weekly, 2020, 1828 (1) : 411 - 411
[34] OsimertinibDevelopment of osimertinib resistance in non-small cell lung cancer with subsequent successful treatment with gefitinib: case report
Reactions Weekly, 2017, 1661 (1) : 255 - 255
[35] CrizotinibDevelopment of crizotinib resistance in metastatic lung cancer: case report
Reactions Weekly, 2018, 1683 (1) : 229 - 229
[36] AlectinibTransformation of lung adenocarcinoma to non-small cell lung cancer following alectinib resistance : case report
Reactions Weekly, 2019, 1765 (1) : 19 - 19
[37] CrizotinibAcquired resistance to crizotinib in non-small lung cancer: case report
Reactions Weekly, 2017, 1648 (1) : 103 - 103
[38] Maintenance treatment with chemotherapy and immunotherapy in non-small cell lung cancer: a case report
Llanos, Anabella
Savignano, Mariana
Cinat, Gabriela
FRONTIERS IN ONCOLOGY, 2012, 2
[39] Development of Hepatocellular Carcinoma During Nivolumab Treatment for Recurrent Non-Small Cell Lung Cancer: A Case Report
Nishikawa, Koji
Okuma, Yusuke
Hashimoto, Kana
Kashima, Jumpei
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 247 (04): : 247 - 250
[40] Chronic myeloid leukemia during osimertinib treatment in a non-small cell lung cancer patient: A case report
Zhang, Libo
Huang, Meijuan
HELIYON, 2024, 10 (17)

← 1 2 3 4 5 →